Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors

Bibliographic Details
Title: Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors
Authors: Antonio E. Barberio, Sean G. Smith, Ivan S. Pires, Sonia Iyer, Ferenc Reinhardt, Mariane B. Melo, Heikyung Suh, Robert A. Weinberg, Darrell J. Irvine, Paula T. Hammond
Source: Bioengineering & Translational Medicine, Vol 8, Iss 2, Pp n/a-n/a (2023)
Publisher Information: Wiley, 2023.
Publication Year: 2023
Collection: LCC:Chemical engineering
LCC:Biotechnology
LCC:Therapeutics. Pharmacology
Subject Terms: cancer immunotherapy, cytokine, drug delivery, layer‐by‐layer, nanomedicine, nanoparticle, Chemical engineering, TP155-156, Biotechnology, TP248.13-248.65, Therapeutics. Pharmacology, RM1-950
More Details: Abstract Ovarian cancer is especially deadly, challenging to treat, and has proven refractory to known immunotherapies. Cytokine therapy is an attractive strategy to drive a proinflammatory immune response in immunologically cold tumors such as many high grade ovarian cancers; however, this strategy has been limited in the past due to severe toxicity. We previously demonstrated the use of a layer‐by‐layer (LbL) nanoparticle (NP) delivery vehicle in subcutaneous flank tumors to reduce the toxicity of interleukin‐12 (IL‐12) therapy upon intratumoral injection. However, ovarian cancer cannot be treated by local injection as it presents as dispersed metastases. Herein, we demonstrate the use of systemically delivered LbL NPs using a cancer cell membrane‐binding outer layer to effectively target and engage the adaptive immune system as a treatment in multiple orthotopic ovarian tumor models, including immunologically cold tumors. IL‐12 therapy from systemically delivered LbL NPs shows reduced severe toxicity and maintained anti‐tumor efficacy compared to carrier‐free IL‐12 or layer‐free liposomal NPs leading to a 30% complete survival rate.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2380-6761
Relation: https://doaj.org/toc/2380-6761
DOI: 10.1002/btm2.10453
Access URL: https://doaj.org/article/da7a5559c1a94ad19eb3527ed8b1cd25
Accession Number: edsdoj.7a5559c1a94ad19eb3527ed8b1cd25
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:23806761
DOI:10.1002/btm2.10453
Published in:Bioengineering & Translational Medicine
Language:English